NM_001371596.2(MFSD8):c.519C>T (p.Ser173=) AND Neuronal ceroid lipofuscinosis 7

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 15, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002858132.4

Allele description [Variation Report for NM_001371596.2(MFSD8):c.519C>T (p.Ser173=)]

NM_001371596.2(MFSD8):c.519C>T (p.Ser173=)

Gene:

MFSD8:major facilitator superfamily domain containing 8 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

4q28.2

Genomic location:

Preferred name:

NM_001371596.2(MFSD8):c.519C>T (p.Ser173=)

HGVS:

NC_000004.12:g.127942079G>A
NG_008657.1:g.28906C>T
NM_001363520.3:c.519C>T
NM_001363521.3:c.439+1673C>T
NM_001371590.2:c.384C>T
NM_001371591.2:c.519C>T
NM_001371592.2:c.519C>T
NM_001371593.2:c.439+1673C>T
NM_001371594.2:c.519C>T
NM_001371595.1:c.384C>T
NM_001371596.2:c.519C>TMANE SELECT
NM_001410765.1:c.304+1673C>T
NM_001410766.1:c.439+1673C>T
NM_152778.4:c.519C>T
NP_001350449.1:p.Ser173=
NP_001358519.1:p.Ser128=
NP_001358520.1:p.Ser173=
NP_001358521.1:p.Ser173=
NP_001358523.1:p.Ser173=
NP_001358524.1:p.Ser128=
NP_001358525.1:p.Ser173=
NP_689991.1:p.Ser173=
LRG_833t1:c.519C>T
LRG_833t2:c.519C>T
LRG_833:g.28906C>T
LRG_833p1:p.Ser173=
LRG_833p2:p.Ser173=
NC_000004.11:g.128863234G>A

Links:

dbSNP: rs1274146586

NCBI 1000 Genomes Browser:

rs1274146586

Molecular consequence:

NM_001363521.3:c.439+1673C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_001371593.2:c.439+1673C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_001410765.1:c.304+1673C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_001410766.1:c.439+1673C>T - intron variant - [Sequence Ontology: SO:0001627]
NM_001363520.3:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371590.2:c.384C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371591.2:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371592.2:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371594.2:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371595.1:c.384C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001371596.2:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_152778.4:c.519C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Neuronal ceroid lipofuscinosis 7 (CLN7)
Synonyms:: MFSD8-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:: MONDO: MONDO:0012588; MedGen: C1838571; Orphanet: 168491; Orphanet: 228366; OMIM: 610951

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003229369	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 15, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003229369

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 15, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003229369.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 173 of the MFSD8 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MFSD8 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with MFSD8-related conditions.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 16, 2025

ClinVar

Relating variation to medicine